Serological DKK1 acquires no diagnostic value in identification of hepatitis B virus related hepatocellular carcinoma
Main Article Content
Keywords
Abstract
Objective: To investigate the clinical significance of serological DKK1 level in the diagnosis of hepatitis B virus (HBV) related hepatocellular carcinoma (HCC). Subject and method: Plasma DKK1 concentrations from 43 HBV carriers, 35 liver cirrhosis related HBV and 112 HCC related HBV were measured by ELISA, whereas receiver operating characteristics (ROC) was used to calculate diagnostic accuracy. Result: The DKK1 levels were not different between HCC and other groups (p>0.05). The value diagnosis of DKK1 was quite low (HCC vs liver cirrhosis, AUC = 0.553, HCC vs chronic hepatitis B, AUC = 0.374). AFP was not supported by DKK1 in the diagnostic performance of HCC (HCC vs liver cirrhosis, AUC (DKK1 + AFP) = 0.691 compared with AUC (AFP) = 0.664, HCC vs chronic hepatitis B, AUC (DKK1 + AFP) = 0.295 compared with AUC - (AFP) = 0.704). Conclusion: Serum DKK1 cannot be used for detection of liver cancer in Vietnam.
Article Details
References
2. Pons F, Varela M, and Llovet JM (2005) Staging systems in hepatocellular carcinoma. HPB (Oxford) 7(1): 35-41.
3. Daniele B et al (2004) α-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127(5): 108-112.
4. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, McCarthy SA (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238(2): 301-313.
5. Shen Q et al (2012) Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre study. The Lancet Oncology 13(8): 817-826.
6. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391: 357-362.
7. Takigawa Y, Brown AM (2008) Wnt signaling in liver cancer. Curr Drug Targets 9(11): 1013-1024.